Freeze Dried Plasma (FDP) Emergency Use Authorization or FDA Licensed Product
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Defense - Operational Medicine (OPMED), under the Defense Health Agency (DHA), is conducting a Sources Sought to identify potential industry partners capable of providing a Freeze Dried Plasma (FDP) product. This product must either be FDA licensed or have a current Emergency Use Authorization (EUA) from the FDA. Responses are due March 25, 2026.
Scope of Work
OPMED is seeking FDP products that are at an advanced stage of development, specifically those that have achieved FDA licensure or possess an active FDA Emergency Use Authorization. The goal is to procure a ready-to-use FDP product for operational medicine needs.
Contract & Timeline
- Type: Sources Sought / Market Research
- Product Service Code: 6515 (Medical And Surgical Instruments, Equipment, And Supplies)
- Set-Aside: None specified
- Response Due: March 25, 2026, 4:15 PM ET
- Published: March 10, 2026
Evaluation
Responses will be used for market research purposes to identify qualified industry partners and assess the availability of suitable FDP products. This information will inform future procurement strategies.
Additional Notes
This notice is for planning purposes only and does not constitute a solicitation or commitment by the Government to award a contract.